News

The trial supplements the EINSTEIN Trial Programme, which established in the EINSTEIN Extension study that rivaroxaban 20mg once daily reduces the risk of long-term prevention of recurrent symptomatic

The deal covers the development and potentially the commercialization of Cellectis’ lead product candidate, UCART19, as well as the research, development, and commercialization of five other product candidates

With the acquisition, DKSH continues its strategic expansion in the industry by adding a direct presence in Macau to its pan-Asian coverage. With the move, DKSH is driving

Financial terms of the transaction are not disclosed. CoStim was founded in 2012 by MPM Capital managing director Luke Evnin together with MPM Capital operations managing director Robert

In addition, Horizon’s customers can now access Sirion’s off-the-shelf validated shRNA and cDNA over-expression reagents. Through the deal, Horizon will now offer a broad spectrum of gene modulation

The randomized, double-blind study is the company’s second cancer therapy approved for clinical trials by the FDA, bolstering its platform approach to treating late stage solid-tumor cancers. The

Under the terms of the merger agreement, which has been approved by the company’s board upon the recommendation of the board’s transaction committee of independent and disinterested directors,

Walgreens Connected Care is an education and support plan designed to help patients achieve a sustained virologic response (SVR) and improved quality of life through medication adherence. The

MuGard is a mucoadhesive hydrogel. The randomized, double-blind, placebo-controlled trial showed MuGard was more effective than a sham-control in significantly reducing pain associated with oral mucositis, a common